Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Seasonal variation and predictors of epistaxis.

Purkey MR, Seeskin Z, Chandra R.

Laryngoscope. 2014 Sep;124(9):2028-33. doi: 10.1002/lary.24679. Epub 2014 Apr 29.

PMID:
24633839
2.

Epidemiology of epistaxes admitted to a tertiary hospital.

Monjas-Cánovas I, Hernández-García I, Mauri-Barberá J, Sanz-Romero B, Gras-Albert JR.

Acta Otorrinolaringol Esp. 2010 Jan-Feb;61(1):41-7. doi: 10.1016/j.otorri.2009.09.003. Epub 2009 Dec 10. English, Spanish.

3.

[A statistical analysis of epistaxis between outpatients and inpatients].

Hasegawa T, Takegoshi H, Kikuchi S, Iinuma T.

Nihon Jibiinkoka Gakkai Kaiho. 2004 Jan;107(1):18-24. Japanese.

PMID:
14969097
4.

Epidemiology of epistaxis in US emergency departments, 1992 to 2001.

Pallin DJ, Chng YM, McKay MP, Emond JA, Pelletier AJ, Camargo CA Jr.

Ann Emerg Med. 2005 Jul;46(1):77-81.

PMID:
15988431
5.

The epidemiology and chronobiology of epistaxis: an investigation of Scottish hospital admissions 1995-2004.

Walker TW, Macfarlane TV, McGarry GW.

Clin Otolaryngol. 2007 Oct;32(5):361-5.

PMID:
17883556
6.

Relationship between epistaxis and hypertension: a study of patients seen in the emergency units of two tertiary health institutions in Nigeria.

Isezuo SA, Segun-Busari S, Ezunu E, Yakubu A, Iseh K, Legbo J, Alabi BS, Dunmade AE, Ologe FE.

Niger J Clin Pract. 2008 Dec;11(4):379-82.

PMID:
19320416
7.

The natural history of epistaxis in hereditary hemorrhagic telangiectasia.

AAssar OS, Friedman CM, White RI Jr.

Laryngoscope. 1991 Sep;101(9):977-80.

PMID:
1886446
8.

Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia.

Silva BM, Hosman AE, Devlin HL, Shovlin CL.

Laryngoscope. 2013 May;123(5):1092-9. doi: 10.1002/lary.23893. Epub 2013 Feb 12.

PMID:
23404156
9.

Natural history and control of epistaxis in a group of German patients with Rendu-Osler-Weber disease.

Folz BJ, Tennie J, Lippert BM, Werner JA.

Rhinology. 2005 Mar;43(1):40-6.

PMID:
15844501
10.

Epistaxis: are temperature and seasonal variations true factors in incidence?

Bray D, Giddings CE, Monnery P, Eze N, Lo S, Toma AG.

J Laryngol Otol. 2005 Sep;119(9):724-6.

PMID:
16156915
11.

[Does clustering exist in non-traumatic epistaxis?].

Olóriz J, Prim MP, Sastre N, Gracia J, de Diego JI.

Acta Otorrinolaringol Esp. 2004 Jan;55(1):23-6. Spanish.

12.

Pattern of epistaxis in Sokoto, Nigeria: a review of 72 cases.

Iseh KR, Muhammad Z.

Ann Afr Med. 2008 Sep;7(3):107-11. Review.

13.

Clinical profile of idiopathic epistaxis in a hospital.

Bhatta R.

JNMA J Nepal Med Assoc. 2012 Oct-Dec;52(188):167-71.

PMID:
23591247
14.

An epistaxis severity score for hereditary hemorrhagic telangiectasia.

Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA.

Laryngoscope. 2010 Apr;120(4):838-43. doi: 10.1002/lary.20818.

PMID:
20087969
15.

Safety of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.

Chen S 4th, Karnezis T, Davidson TM.

Laryngoscope. 2011 Mar;121(3):644-6. doi: 10.1002/lary.21345. Epub 2010 Nov 11.

PMID:
21344447
16.

Epistaxis in Port Harcourt.

Okoye BC, Onotai LO.

Niger J Med. 2006 Jul-Sep;15(3):298-300.

PMID:
17111764
17.

Demographic, Seasonal, and Geographic Differences in Emergency Department Visits for Epistaxis.

Chaaban MR, Zhang D, Resto V, Goodwin JS.

Otolaryngol Head Neck Surg. 2017 Jan;156(1):81-86. doi: 10.1177/0194599816667295. Epub 2016 Oct 3.

PMID:
27625026
18.

Posterior epistaxis: clinical features and acute complications.

Viducich RA, Blanda MP, Gerson LW.

Ann Emerg Med. 1995 May;25(5):592-6.

PMID:
7741333
19.

Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.

Karnezis TT, Davidson TM.

Laryngoscope. 2011 Mar;121(3):636-8. doi: 10.1002/lary.21415. Epub 2010 Dec 16.

PMID:
21344445
20.

Supplemental Content

Support Center